795.33MMarket Cap-2150P/E (TTM)
2.245High2.150Low1.78MVolume2.240Open2.260Pre Close3.87MTurnover0.74%Turnover RatioLossP/E (Static)369.92MShares3.16052wk High1.38P/B517.15MFloat Cap1.57052wk Low--Dividend TTM240.54MShs Float49.455Historical High--Div YieldTTM4.20%Amplitude0.920Historical Low2.174Avg Price1Lot Size
Standard BioTools Stock Forum
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet